Generex Biotechnology Corporation Aktie OTC Bulletin Board
Aktien
US3714851033
Biotechnologie
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
2022 | Unfreiwillige Petition für Generex Biotechnology Corporation genehmigt | CI |
2022 | Unfreiwillige Petition gegen Generex Biotechnology Corporation eingereicht | CI |
Manager | Titel | Alter | Seit |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 21.11.17 |
Mark Carrao
DFI | Director of Finance/CFO | - | 01.01.17 |
Terry Thompson
COO | Chief Operating Officer | 65 | 25.06.18 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Brian T. McGee
BRD | Director/Board Member | 63 | 01.03.04 |
Eric von Hofe
PRN | Corporate Officer/Principal | 66 | 01.01.05 |
Craig Eagle
BRD | Director/Board Member | 57 | 21.11.17 |
% 1. Jan. | Kap. | |
---|---|---|
+11.91% | 118 Mrd. | |
+11.60% | 106 Mrd. | |
-4.68% | 24.28 Mrd. | |
-0.82% | 21.96 Mrd. | |
-10.12% | 18.16 Mrd. | |
-42.12% | 16.37 Mrd. | |
-17.47% | 15.56 Mrd. | |
+2.77% | 13.63 Mrd. | |
+34.58% | 12.27 Mrd. |
- Börse
- Aktien
- A2DL9M Aktie
- Aktie